# A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

> **NCT02503189** · PHASE3 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.**

## Conditions studied

- Dry Eye With Sjögren's Syndrome

## Interventions

- **DRUG:** KCT-0809 ophthalmic solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02503189
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2017-01
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2017-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02503189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02503189, "A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02503189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*